MR Imaging Accurately Determines Prostate Cancer Treatment Failure

Main Category: MRI / PET / Ultrasound
Also Included In: Prostate / Prostate Cancer
Article Date: 21 May 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:4 stars

4 (1 votes)


Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.

The study included 27 patients who had increased levels of prostate specific antigen after being treated with high-intensity focused ultrasonic (HIFU) ablation; 18 of these patients had local tumor progression seen at biopsy. DCE-MRI and DWI had about a 72% accuracy rate in determining which patients needed additional treatment because they had residual or recurrent cancer, said Chan Kyo Kim, MD, lead author of the study. The study found that DWI had fewer false positives than DCE-MRI, but DCE-MRI had fewer false negatives.

"After HIFU ablation, the normal anatomy of the prostate gland is completely lost or deformed making it difficult to distinguish benign tissue from cancer," said Dr. Kim. The two imaging studies together, which can be done in about seven minutes, can overcome that challenge, he said.

HIFU is becoming more common as a prostate cancer treatment option, particularly for those persons who can't or don't want to undergo a radical prostatectomy, said Dr. Kim.

The study appears in the May issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society.

Click here for the abstract.

About ARRS

The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS Annual Meeting to take part in instructional courses, scientific paper presentations, and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Röentgen, who discovered the X-ray in 1895.

American Roentgen Ray Society

Article adapted by Medical News Today from original press release.
Visit our mri / pet / ultrasound section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
American Roentgen Ray Society. "MR Imaging Accurately Determines Prostate Cancer Treatment Failure." Medical News Today. MediLexicon, Intl., 21 May. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/108091.php>

APA
American Roentgen Ray Society. (2008, May 21). "MR Imaging Accurately Determines Prostate Cancer Treatment Failure." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/108091.php.

Please note: If no author information is provided, the source is cited instead.




MRI / PET / Ultrasound

Most Popular Articles



Follow Our MRI News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our MRI / PET / Ultrasound Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »